Scribd Logo
Upload

Welcome to Scribd!

  • 17 views

    Sapm

    Uploaded by

    aditya.babar
    The document provides an overview of the pharmaceutical industry in India. It discusses that India is the largest supplier of generic drugs worldwide and has a thriving pharmaceutical industry growing at 9.43% CAGR. It also outlines that major players in the Indian pharma industry include Dr. Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Zydus Lifesciences, and Aurobindo Pharma. Financial details are presented on Sun Pharma's profits, assets, and current investments from 2020-2023. The conclusion emphasizes balancing profit motives with affordable healthcare and ethical research being important for the industry's success and public trust.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Sapm

    Uploaded by

    aditya.babar
    17 views10 pages
    The document provides an overview of the pharmaceutical industry in India. It discusses that India is the largest supplier of generic drugs worldwide and has a thriving pharmaceutical industry growing at 9.43% CAGR. It also outlines that major players in the Indian pharma industry include Dr. Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Zydus Lifesciences, and Aurobindo Pharma. Financial details are presented on Sun Pharma's profits, assets, and current investments from 2020-2023. The conclusion emphasizes balancing profit motives with affordable healthcare and ethical research being important for the industry's success and public trust.

    Original Description:

    Original Title

    sapm (2)

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document provides an overview of the pharmaceutical industry in India. It discusses that India is the largest supplier of generic drugs worldwide and has a thriving pharmaceutical industry growing at 9.43% CAGR. It also outlines that major players in the Indian pharma industry include Dr. Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Zydus Lifesciences, and Aurobindo Pharma. Financial details are presented on Sun Pharma's profits, assets, and current investments from 2020-2023. The conclusion emphasizes balancing profit motives with affordable healthcare and ethical research being important for the industry's success and public trust.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    17 views10 pages

    Sapm

    Uploaded by

    aditya.babar
    The document provides an overview of the pharmaceutical industry in India. It discusses that India is the largest supplier of generic drugs worldwide and has a thriving pharmaceutical industry growing at 9.43% CAGR. It also outlines that major players in the Indian pharma industry include Dr. Reddy's Laboratories, Cipla, Torrent Pharmaceuticals, Zydus Lifesciences, and Aurobindo Pharma. Financial details are presented on Sun Pharma's profits, assets, and current investments from 2020-2023. The conclusion emphasizes balancing profit motives with affordable healthcare and ethical research being important for the industry's success and public trust.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as pptx, pdf, or txt
    of 10

    Topic

    Financial analyses of
    pharma industry
    Subject

    Security and portfolio analyses


    CA - 3

    Presented by
    Aditya Babar
    Introduction to pharma industry

     India is the biggest supplier of nonexclusive medications worldwide and is known for
    its reasonable immunizations and conventional prescriptions
     . The Indian Drug industry is presently positioned third in drug creation by volume in
    the wake of developing over the long haul into a flourishing industry developing at a
    CAGR of 9.43% since the beyond nine years.
     Conventional medications, non-prescription meds, mass medications, immunizations,
    contract research and assembling, biosimilars, and biologics are a portion of the
    significant sections of the Indian pharma industry.
     India has the most number of drug fabricating offices that are in consistence with the
    US Food and Medication Organization (USFDA) and has 500 Programming interface
    makers that make for around 8% of the overall Programming interface market.
    Major players of pharma industry

     Dr. Reddy's Laboratories Ltd. India. ...


     Cipla Ltd. India. ...
     Torrent Pharmaceuticals Ltd. India. ...
     Zydus Lifesciences Ltd. India. ...
     Aurobindo Pharma Ltd. India. ...
     Alkem Laboratories Ltd. India. ...
     Lupin Ltd. India.
    Sun pharma expenditures

    Source- money control


    Unit – (cr) 2023 2022 2021 2020
    Profit ratio
    Profits of sun pharma

    2023 2022 2021 2020

    Unit – (cr)
    Sun pharma industry (Assets)

    Total current assets

    2023 2022 2021 2020


    Sun pharma industries

    Sun pharma industries current in-


    vestment
    11

    2023 2022 2021 2020 2019


    Profit 7.59 8 10 6.5 ) 6.9
    Conclusion

     The drug area is a basic industry with massive potential for development and life-
    saving headways. Nonetheless, it additionally faces difficulties like high medication
    costs, availability issues, and worries about moral practices.

     Offsetting benefit intentions with reasonable medical care and moral exploration is vital
    for the business' general achievement and public trust. Coordinated efforts,
    straightforwardness, and administrative structures that energize both advancement and
    impartial admittance to meds are critical to tending to these intricacies.


    Reference

     www.moneycontrol.com
     www.google.com
    Thank you

    You might also like